Carenet Health has acquired Invene, a healthcare-focused AI and data engineering consulting firm. The acquisition adds deep AI, data, and technology expertise to Carenet’s growing healthcare engagement capabilities.
San Antonio, Texas – Oct. 15, 2026 – Carenet Health (Carenet), the engagement, navigation, and clinical execution partner to America’s leading payers, providers, and health technology and services companies, today announced its acquisition of Invene, a healthcare-only AI and data engineering consulting firm trusted by 20 of the Fortune 100.
Healthcare organizations need technology, AI, and data investments to deliver measurable results. Invene helps them decide what is worth developing, strengthen the data foundations beneath it, and architect technology that works in real-world workflows. Its team has launched 400+ products touching more than 1 billion users worldwide, won more than 30 innovation awards, and made the Inc. 5000 two years running.
“Healthcare companies want to put AI to work responsibly and profitably, with a partner who can orchestrate, build, and run it,” said Christopher Rogers, President of Carenet Health. “Invene has done exactly that with many formidable healthcare organizations. Paired with our Intelligent Engagement™ technology, clinical foundations, global operations, and decades of healthcare insights, clients get one powerhouse partner that’s accountable from strategy to implementation and optimization at scale.”
“We built Invene to solve the hardest technology problems in healthcare. Carenet deepens our ability to do this end-to-end, with more organizations,” said James Griffin, Invene founder, and now President of Invene, a Carenet Health company. “Our clients gain a proven, full-service healthcare engagement partner, and Carenet’s clients benefit from our deep expertise in data and AI.”
Since its founding in 2018, Invene’s remote, U.S.-based workforce has delivered cutting-edge solutions to payers, providers, value-based care organizations, EHRs, and health-tech companies. It helps organizations reduce manual effort with expertise in AI innovation strategy, agentic AI and automation, and healthcare data engineering and interoperability.
Griffin and the experienced Invene team, along with its nationwide network of independent technical consultants and engineers, join Carenet immediately. As a Carenet Health company, Invene will continue to serve healthcare organizations beyond Carenet’s client base and vice versa.
“We’re building a different kind of healthcare engagement company — one that combines the power of advanced tech and AI with consumer intelligence, clinical expertise, and operational scale to deliver what matters most: better outcomes,” said John Erwin, CEO of Carenet Health. “We’re deliberate about what we build, what we acquire, and who we partner with. Every investment has a purpose, and that purpose is to make our clients more successful and healthcare more accessible, affordable, and effective for the people they serve.”
Invene is Carenet’s 12th acquisition, following Orbita earlier this week.
Key Acquisition Higlights
- Adds a healthcare-only AI, data engineering, and technology consulting practice to Carenet’s full-service healthcare engagement suite
- Invene has delivered for 20 of the Fortune 100, launched 400+ products, served 1B+ healthcare consumers, and been named to the Inc. 5000 in 2025 and 2026
- Invene operates as a Carenet Health company under founder James Griffin, a Forbes Next 1000 honoree
- Carenet clients gain technical consulting expertise in AI strategy, agentic AI, EMR interoperability, and healthcare data engineering
- Carenet’s 12th acquisition in 9 years, reinforces its commitment to continuously strengthen its AI and technology foundation, clinical acumen, global operations, and value-add for healthcare payer, provider, and services clients
What Invene Does
Invene serves payers, providers, value-based care organizations, EHRs, and health technology firms. Its fully remote U.S.-based team works across hub cities including Dallas, Boston, Nashville, and Tampa.
Practice | What it does | Business impact |
Product Strategy | Identifies and validates high-ROI AI and technology opportunities before anything is built, grounded in real workflows and technical constraints | Build-ready plans tied to measurable ROI; lower investment risk |
Data Engineering | Modernizes data platforms, pipelines, and integrations — including data lakes, cloud migrations, FHIR/HL7, X12 EDI, and EMR data | Reliable reporting and an AI-ready data foundation |
AI & Product Engineering | Designs and builds AI agents, predictive analytics, and HIPAA-compliant applications that fit clinical, administrative, and operational settings | Automation that ships, scales, and self-optimizes in production |
Business Transformation | Embeds senior technical leadership (including interim CTO & CIO support) to diagnose issues, align stakeholders, and drive delivery | Faster turnaround, lower operating cost, and clear accountability |
Implementation Partnership | Operationalizes enterprise platforms through onboarding, integration, and change management | Adoption that sticks after go-live |
Proven Results
- Value-based care: Invene embedded interim CTO leadership at a leading VBC organization and, within 12 weeks, surfaced a $20 million cost gap and set a roadmap to protect EBITDA.
- Revenue cycle: For FinThrive, Invene automated payer-specific data pipelines that eliminated more than 20,000 hours of manual effort.
- Predictive AI: Invene led UX strategy for ClosedLoop’s platform, which won the CMS AI Health Outcomes Challenge and earned Best in KLAS for Healthcare AI in 2023.
- Agentic AI: Invene designed and built multi-agent clinical automation for Onpoint Healthcare Partners, speeding time-to-launch for new clinical use cases.
Why It Matters
Payers, providers, and health technology companies are moving from AI pilots to production. The hard part is rarely the model; it’s the data foundation, the workflow fit, and the operating model around it. Carenet already combines AI-powered Intelligent Engagement™ technology with clinical and non-clinical teams at scale. Invene amplifies Carenet’s strategy, product, and engineering expertise to design, build, and integrate new technology. Now one partner can take an initiative from idea to production, enabling the largest healthcare organizations to receive transformative results.
About Carenet Health
Carenet Health is the leading healthcare engagement partner to America’s payers, providers, and health technology and services companies – helping them grow and lower costs, as they make healthcare more accessible, affordable, and effective. For more than 20 years, Carenet has combined advanced technology, data insights, clinical expertise, and global talent to drive operational efficiency, better experiences, and meaningful business and health outcomes. Learn more at carenethealth.com.
Media contact
Ally Thomson
Vice President, Marketing and Enablement
agthomson@carenethealth.com
Investor contact
Danny Despot
Head of Corporate Development
drdespot@carenethealth.com
Frequently Asked Questions (FAQ)
What did Carenet Health acquire? Invene, a healthcare-only AI, data engineering, and technology consulting firm founded by James Griffin in 2018. Invene operates as a Carenet Health company as of October 2026.
Why did Carenet Health acquire Invene? To give healthcare companies a single partner for AI strategy, data engineering, technology build, and human-plus-AI engagement operations, and to deepen Carenet’s AI and technical consulting expertise and drive improvements at scale.
What changes for Invene clients? Nothing disruptive. Clients keep the same Invene team, engagements, and points of contact, while gaining access to Carenet’s broader suite of engagement services, technology, insights, and BPO operations.
What’s new for Carenet clients? Direct access to Invene’s AI strategy, agentic AI, data engineering, interoperability, and product development expertise.
Does Invene still work with organizations that aren’t Carenet clients? Yes. Invene continues to serve payers, providers, VBC organizations, EHRs, and health technology companies, whether or not they work with Carenet. Likewise, not all Carenet clients will engage with Invene’s services.
Who leads Invene? Founder James Griffin, a Forbes Next 1000 honoree, now President of Invene, a Carenet Health company.
How many acquisitions has Carenet Health made? Invene is Carenet’s 12th acquisition in nine years, following Orbita (2026), Response f.k.a. Response BPO (2026), Launch f.k.a. Balto Health (2025), and Health Dialog (2024).
